The MarketWatch News Department was not involved in the creation of this content. Milestone underscores continued momentum in commercial rollout and accelerating adoption of neuroimmune modulation as ...

Northwell Health was one of many who conducted a pioneering clinical trial to treat rheumatoid arthritis through a chip implanted on the vagus nerve. The first technology of its kind yielded ...

SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic ...

The US Food and Drug Administration (FDA) recently approved a medical device that could bring new hope to patients suffering from rheumatoid arthritis (RA), a chronic autoimmune condition often ...

Credit: SetPoint Medical. The SetPoint System is a rechargeable neurostimulation device that is implanted on the vagus nerve. Treatment with the SetPoint System, a neuroimmune modulation device, was ...

An innovative new device calms inflammation by delivering a low-voltage jolt of electricity to the vagus nerve. The FDA has approved the SetPoint System, a device implanted in the neck for relieving ...

PENSACOLA, FL, UNITED STATES, April 22, 2026 /EINPresswire.com/ — Lovell ® Government Services and SetPoint Medical, a commercial-stage medical technology company ...

VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today announced late-breaking data from the ...

VALENCIA, Calif., May 4, 2026 /PRNewswire/ -- SetPoint Medical, a medical technology company dedicated to improving care for people living with chronic autoimmune diseases, today announced that ...

Milestone underscores continued momentum in commercial rollout and accelerating adoption of neuroimmune modulation as a new option for adults living with Rheumatoid Arthritis "The SetPoint System ...